At Long Last, Renal Denervation Hits the US Market; What Can We Expect?
In November, FDA approved renal denervation systems from Medtronic and Recor Medical as adjunctive treatments for people with hypertension. The label is broad, and the technology addresses a huge unmet need, but just how far, and how fast, will this new device market go?
Read Article